Works matching IS 00302414 AND DT 2019 AND VI 97 AND IP 2


Results: 8
    1

    Front & Back Matter.

    Published in:
    Oncology, 2019, v. 97, n. 2, p. N.PAG, doi. 10.1159/000502396
    Publication type:
    Article
    2
    3

    A Phase 1b/2 Study of the Bruton Tyrosine Kinase Inhibitor Ibrutinib and the PD-L1 Inhibitor Durvalumab in Patients with Pretreated Solid Tumors.

    Published in:
    Oncology, 2019, v. 97, n. 2, p. 102, doi. 10.1159/000500571
    By:
    • Hong, David;
    • Rasco, Drew;
    • Veeder, Michael;
    • Luke, Jason J.;
    • Chandler, Jason;
    • Balmanoukian, Ani;
    • George, Thomas J.;
    • Munster, Pamela;
    • Berlin, Jordan D.;
    • Gutierrez, Martin;
    • Mita, Alain;
    • Wakelee, Heather;
    • Samakoglu, Selda;
    • Guan, Shanhong;
    • Dimery, Isaiah;
    • Graef, Thorsten;
    • Borazanci, Erkut
    Publication type:
    Article
    4
    5
    6
    7
    8